Abcellera Biologics

-$0.25 (-1.61%) Today
$0.00 (0.00%) As of 9:13 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABCL and other ETFs, options, and stocks.

About ABCL

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease.

CEO
Carl Lars G. Hansen
Employees
206
Headquarters
Vancouver, British Columbia
Founded
2012

ABCL Key Statistics

Market Cap
4.26B
Price-Earnings Ratio
18.43
Dividend Yield
—
Average Volume
1.61M
High Today
$15.75
Low Today
$15.17
Open Price
$15.40
Volume
1.07M
52 Week High
$71.91
52 Week Low
$14.51

ABCL News

Simply Wall StOct 16

Could The AbCellera Biologics Inc. Ownership Structure Tell Us Something Useful?

The big shareholder groups in AbCellera Biologics Inc. (NASDAQ:ABCL) have power over the company. Insiders often own a large chunk of younger, smaller, companie

ABCL Earnings

-$0.03
$0.18
$0.40
$0.61
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
-$0.03 per share
Actual
Available Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure